Clinical trial
Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer
NCT00014066 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00014066 |
|---|---|
| Title | Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer |
| Official title | A Phase I Study of Photodynamic Therapy (PDT) Combined With High Dose Rate (HDR) Brachytherapy for Patients With Obstructive Bronchogenic Carcinoma |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | hematoporphyrin derivative, brachytherapy |
| Start date | Mar 1, 1993 |
| Primary completion | Feb 1, 2004 |
| First posted | Feb 4, 2004 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: